TriMas (TRS) Expected to Announce Quarterly Earnings on Tuesday

TriMas (NASDAQ:TRS - Get Free Report) is anticipated to post its Q1 2025 quarterly earnings results before the market opens on Tuesday, April 29th. Analysts expect TriMas to post earnings of $0.43 per share and revenue of $235.41 million for the quarter.

TriMas Stock Performance

Shares of TRS traded down $0.06 during midday trading on Friday, reaching $21.33. The stock had a trading volume of 712,885 shares, compared to its average volume of 311,381. The firm has a market cap of $868.47 million, a PE ratio of 33.33 and a beta of 0.55. The company has a current ratio of 2.83, a quick ratio of 1.44 and a debt-to-equity ratio of 0.60. The firm has a 50 day simple moving average of $22.39 and a 200-day simple moving average of $24.39. TriMas has a one year low of $19.33 and a one year high of $28.51.

TriMas Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 13th. Stockholders of record on Tuesday, May 6th will be issued a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date is Tuesday, May 6th. TriMas's dividend payout ratio is presently 27.12%.

Insiders Place Their Bets

In other TriMas news, Director Jeffrey A. Fielkow purchased 2,500 shares of the firm's stock in a transaction dated Friday, February 28th. The shares were bought at an average price of $20.78 per share, for a total transaction of $51,950.00. Following the purchase, the director now owns 11,013 shares in the company, valued at approximately $228,850.14. This trade represents a 29.37 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Shawn Sedaghat purchased 554,149 shares of the firm's stock in a transaction dated Monday, March 10th. The stock was acquired at an average price of $24.07 per share, for a total transaction of $13,338,366.43. Following the purchase, the director now owns 900,974 shares in the company, valued at approximately $21,686,444.18. The trade was a 159.78 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 806,246 shares of company stock worth $19,338,213 in the last 90 days. Company insiders own 14.20% of the company's stock.

Analyst Upgrades and Downgrades

Separately, BWS Financial reiterated a "buy" rating and set a $40.00 target price on shares of TriMas in a research note on Friday, February 28th.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.